Aspirin Offers No Improved Survival or Recurrence Benefit
Previous observational studies and several randomized trials have demonstrated a reduction in cancer risk and risk of metastasis, including for breast cancer (BC), with the use of aspirin. However, these results were often secondary findings. To help …